personalized treatment

Building Towards Initiation, Moderation, De-Escalation and Cessation of Disease-Modifying Treatments for Multiple Sclerosis in Greece: An Expert Panel Consensus Meeting

Expert Consensus on Treatment Approaches The management of multiple sclerosis (MS) requires a nuanced understanding of various treatment modalities, including

Building Towards Initiation, Moderation, De-Escalation and Cessation of Disease-Modifying Treatments for Multiple Sclerosis in Greece: An Expert Panel Consensus Meeting Read Post »

Functional Neurological Disorder: Neurobiological Mechanisms, Biomarkers, and Integrated Treatment in a Female-Predominant Neuropsychiatric Condition

Neurobiological Mechanisms Functional Neurological Disorder (FND) is characterized by neurological symptoms that cannot be explained by traditional neurological diseases. Research

Functional Neurological Disorder: Neurobiological Mechanisms, Biomarkers, and Integrated Treatment in a Female-Predominant Neuropsychiatric Condition Read Post »

Low-Positive Myelin Oligodendrocyte Glycoprotein (MOG)-Immunoglobulin G (IgG) in Pediatric Demyelinating Disease: How Imaging Features Can Support a MOG Antibody-Associated Disease (MOGAD) Diagnosis

Clinical Features of MOGAD in Pediatrics MOG-antibody associated disease (MOGAD) presents with a spectrum of symptoms that can vary widely

Low-Positive Myelin Oligodendrocyte Glycoprotein (MOG)-Immunoglobulin G (IgG) in Pediatric Demyelinating Disease: How Imaging Features Can Support a MOG Antibody-Associated Disease (MOGAD) Diagnosis Read Post »

Scroll to Top